GlassScriptPhysician profile
Philip C Mirmelli
NPI 1982667705
$2,447.55
in general payments reported to CMS, 2019-2025
19 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $146 · 2021: $161 · 2022: $402 · 2023: $559 · 2024: $451 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,299.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,129.97 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $249.04 | 2020-2024 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $239.55 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.78 | 2019-2020 | |
| Genzyme Corporation | $141.53 | 2022-2023 | |
| Optinose US, INC. | $106.16 | 2019-2024 | |
| Alk-Abello, INC | $55.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $51.59 | 2021-2025 | |
| Aimmune Therapeutics, INC. | $49.36 | 2020-2022 | |
| Genentech USA, INC. | $38.65 | 2019-2022 | |
| Csl Behring | $32.21 | 2024 | Haegarda |
| Ars Pharmaceuticals Operations, INC. | $27.16 | 2025 | Neffy |
| Amgen INC. | $27.06 | 2021 | |
| Azurity Pharmaceuticals, INC. | $26.76 | 2025 | Alvesco |
| Pfizer INC. | $23.31 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $21.48 | 2025 | Vtama |
| Horizon Therapeutics Plc | $21.19 | 2021 | |
| Grifols USA, LLC | $20.55 | 2019 | |
| Pharming Healthcare, INC. | $15.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Mirmelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.